|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.60 SEK | +0.41% |
|
-8.20% | -13.27% |
| Market Cap | 1.04B 108M 94.18M 87.1M 79.93M 151M 10.38B 154M 408M 5.07B 405M 396M 17.5B | P/E 2026 * |
-13.1x | P/E 2027 * | -25.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.02B 106M 92.6M 85.63M 78.58M 149M 10.21B 151M 401M 4.98B 398M 389M 17.21B | EV / Sales 2026 * |
7.36x | EV / Sales 2027 * | 50.3x |
| Free-Float |
70.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SynAct Pharma AB
| 1 day | +1.23% | ||
| 1 week | -8.20% | ||
| Current month | -6.89% | ||
| 1 month | +77.54% | ||
| 3 months | +12.51% | ||
| 6 months | -17.65% | ||
| Current year | -13.27% |
| 1 week | 19.38 |  | 23.5 |
| 1 month | 10.16 | | 23.5 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.75 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 01/01/2014 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 01/03/2026 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 15/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 20/03/2024 |
Anders Kronborg
CHM | Chairman | 62 | 20/03/2024 |
Sten Scheibye
BRD | Director/Board Member | 74 | 20/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/3/26 | Buy | Chairman | 2,750 | 0.0052% | ||
| 9/3/26 | Buy | Executive/Senior Manager | 1,500 | 0.0028% | ||
| 9/3/26 | Quantass ApS
| Buy | Company | 7,900 | 0.0148% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.41% | -8.20% | -8.20% | -76.83% | 108M | |
| +1.62% | -3.70% | +48.38% | +162.09% | 1,031B | |
| +1.25% | -3.69% | +51.44% | +56.87% | 595B | |
| +3.40% | +0.67% | +32.02% | +86.60% | 431B | |
| +0.42% | -1.16% | +29.43% | +23.64% | 326B | |
| +1.03% | -0.84% | +29.58% | +45.15% | 277B | |
| +0.49% | -5.44% | +21.00% | +23.80% | 263B | |
| +1.59% | +4.89% | -22.56% | -37.35% | 224B | |
| +3.03% | +1.35% | +23.24% | +61.75% | 193B | |
| +2.37% | -0.12% | +22.60% | +73.82% | 164B | |
| Average | +1.58% | -3.32% | +22.69% | +41.95% | 350.44B | |
| Weighted average by Cap. | +1.59% | -4.31% | +34.46% | +80.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 139M 14.39M 12.58M 11.63M 10.68M 20.21M 1.39B 20.56M 54.51M 677M 54.05M 52.86M 2.34B | 21.15M 2.19M 1.92M 1.77M 1.63M 3.08M 211M 3.13M 8.31M 103M 8.24M 8.06M 356M |
| Net income | 52.18M 5.41M 4.73M 4.37M 4.01M 7.6M 522M 7.73M 20.5M 255M 20.32M 19.88M 879M | -26.04M -2.7M -2.36M -2.18M -2M -3.79M -260M -3.86M -10.23M -127M -10.15M -9.92M -439M |
| Net Debt | -17.48M -1.81M -1.58M -1.47M -1.34M -2.55M -175M -2.59M -6.87M -85.32M -6.81M -6.66M -295M | 24.86M 2.58M 2.25M 2.08M 1.91M 3.62M 248M 3.68M 9.77M 121M 9.68M 9.47M 419M |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | SEK 19.60 | +0.41% | 105,576 |
| 15/07/26 | SEK 19.52 | -2.89% | 127,568 |
| 14/07/26 | SEK 20.10 | -4.74% | 134,541 |
| 13/07/26 | SEK 21.10 | -3.21% | 205,728 |
| 10/07/26 | SEK 21.80 | +2.11% | 432,670 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
